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yOur society is awash with cheap food,
high in calories and salt. Currently over
two thirds of Americans are overweight,
with a third considered obese. Consumer
advocacy groups are lobbying food
manufacturers to market healthier foods
and drinks, even pushing taxes on sugary
sodas.
Unfortunately, stripping the sugar, fat,
and salt also strips away taste. But geno-
mics advances could indirectly save our
cookies, as molecular biology meets taste
perception. Companies like San Diego-
based Semonyx (http://www.senomyx.
com) are using drug discovery techniques
to engineer a new generation of taste
enhancers that can fool our tastebuds.
Senomyx targets G protein-coupled
receptors for sweet, bitter, and savoryhe surface of particular taste receptor
ells. Savory taste receptors consist of
1R1 and T1R3 proteins. The selectivity
f these heterodimeric receptors for
weet or savory is determined by the
ombination of receptor subunits. The
1R3 protein is used by both the sweet
nd savory taste receptors.
There are 25 receptors for bitter taste,
2 of which have known function. This
lethora of bitter receptors is believed to
e due to nearly all naturally occurring
oxins tasting bitter. Some people are
ore sensitive to bitter taste because of
olymorphisms in their receptor genes.
here may be polymorphisms in the regu-
atory system for sweet perception as
ell. People can sense fat, but it is not
et understood how. The salt receptor isBut genomics advances could indirectly save our cookies, as
molecular biology meets taste perception.tastes and ion channels for saltiness. In
addition, the company is developing bitter
blockers and menthol cooling agents.
‘‘I think there is great interest in big
food and fragrance companies and entre-
preneurial companies like Senomyx and
Redpoint to try to find technological
ways to make food healthier.’’ said Gary
Beauchamp, Ph.D., director of the Monell
Chemical Senses Center. ‘‘The trouble is
that if you look at the history of public
health organizations telling you to eat
a healthier diet, the results are not very
encouraging.’’
Good Taste Is a Matter
of Perception
Humans can taste five different tastes:
sweet, sour, bitter, salty, and umami
(savory). It has long been known that taste
is linked to sense of smell. Research
groups continue to explore the function
of distinct taste receptors on the tongue
and on the lining of the gut. The human
sweet receptor is comprised of two
proteins, T1R2 and T1R3, expressed onstill unknown but is hypothesized to be
through ion channels.
Zuker Is Sugar in German
‘‘Rapid progress over the past five plus
years has been enabled by the sequenc-
ing of the Human Genome.’’ said Grant
Dubois, Ph.D., research fellow at The
Coca-Cola Company, one of the largest
users of sweeteners in the world. ‘‘[To
find the sequence of the gene of the
human sweet receptor] people were
staying up round the clock watching
what was published on the NIH website,’’
Dubois said.
The first to do this, according to Dubois,
was the collaborative group of Charles
Zuker, professor of Biological Sciences
and Neurobiology at the University of Cal-
ifornia, San Diego (now at Columbia), and
Nicholas Ryba, D.Phil., at the National
Institute of Dental and Craniofacial
Research (NIDCR). Their groups were
the most advanced in the rodent model
system. In 1999, Zuker’s and Ryba’s
groups published work on the sweetChemistry & Biology 16, November 25, 2009receptor, characterizing three members
of the T1R family of G protein-coupled
receptors (Hoon et al., 1999). That same
year, Zuker, Nobel Laureate Roger Tsien,
also from UCSD, and Lubert Stryer from
Stanford Medical School, founded Seno-
myx. Zuker’s and Ryba’s groups further
published research on the T2R family of
bitter taste receptors on the tongue and
palate in 2000, findings on the shared
circuitry of the sweet and umani receptor
in 2003, and research on the sour
receptor in 2006 (Chandrashekar et al.,
2006).
The Search for Sweet at Coke
In the mid 90s at The Coca-Cola Com-
pany, Dubois was exploring low-calorie
sweetness enhancement. ‘‘I knew that it
didn’t make sense to look for new sweet-
eners,’’ Dubois recalled. ‘‘I recognized
that we were never going to be able to
come up with a noncaloric sweetener
that tasted just like sugar.’’ Dubois envi-
sioned a simple small-molecule com-
pound that would bind to the sweet
receptor without activating it, causing
a lower level of sugar to activate it instead.
‘‘You’ve got this receptor that is shaped
like a Venus fly trap,’’ said Dubois. ‘‘When
it closes on a sugar molecule, then the
receptor is in its active form.’’ With an
enhancer that bound on the receptor
and didn’t cause it to close, but allowed
it to stay closed longer after sugar was
bound, his company could make a soda
with half the sugar that would taste the
same as a full-calorie drink. ‘‘It was
a simple idea,’’ said Dubois. ‘‘But it prob-
ably would have taken us another thou-
sand years at the rate we were working
on it, as the only way we had to test it
would be by human taste.’’
Senomyx had the receptor actually
cloned into a heterologous cell system.
‘‘With one analyst they could screen in
the neighborhood of ten thousand com-
pounds per day,’’ Dubois recalled. The
Coca-Cola Company initiated a collabora-
tion with Senomyx in 2002, leading toª2009 Elsevier Ltd All rights reserved 1123
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Innovationsproof of concept with two sweetness
enhancers cleared for use in the U.S.
Dubois reports that the enhancers work
as initially envisioned.
Swish and Spit Methodology
In a room at Senomyx, taste panelists
selected for the sensitivity of their palates
drink liquid and spit it into cups. They are
evaluating candidate compounds that
surface through Senomyx’s high through-
put screening program. ‘‘They get better
at it over time,’’ says Don Karanewsky,
Ph.D., senior vice president, Discovery.
The company’s corporate compound
library contains more than 400,000
synthetic molecules and about 200,000
fractionated natural product extracts.
According to Karanewsky, compounds
are selected for physical properties con-
sidered ‘‘food friendly.’’ The compounds
are optimized for potency in Semonyx’s
proprietary cell-based receptor assays
as well as for heat tolerance, stability,
safety, and solubility.
Semonyx’s sucralose enhancer S2383,
as well as its sucrose enhancer S6973,
received the Flavor and Extract Manufac-
turers Association (FEMA) Generally Rec-
ognized As Safe (GRAS) status. Accord-
ing to Karanewsky, different sweeteners
require different enhancers.
The company has so far identified
blockers for 18 bitter receptors. ‘‘We
have found ligands or molecules that
have acted on 22 out of 25 receptors,’’
said Karanewsky. The company is also
looking for cool flavor enhancers.
In addition to the Coca-Cola collabora-
tion, Semonyx has a licensing agreement
with Firmenich for its sucrose enhancer
S6973 and other enhancers of sucrose,
fructose, and various forms of Rebaudio-
side (stevia, a natural sweetener), which
could net more than $34.5 million if all
milestones are met. The company also is
collaborating with Ajinomoto Co., Inc.;
Cadbury plc; Campbell Soup Company;
and Solae. Nestle´ now uses a Senomyx
savory flavor ingredient.
Senomyx flavor and food producer
customers also have in-house programs.
The company’s products compete with
existing food chemistry methods. The
121 employee company went public in
June 2004. Semonyx is capitalized at1124 Chemistry & Biology 16, November 25,$33 million as of September 30, 2009,
but projects losses over the next two
years.
The Discriminating Rodents
of Redpoint Bio
Ewing, New Jersey, based Redpoint Bio
(http://www.redpointbio.com) focuses on
taste biology to develop drugs for dia-
betes that control metabolism as well as
natural taste enhancers to reduce the
calorie content of sweetened foods. The
now 12 person company (restructured
this spring) originally focused on using
molecular cloning and screening tech-
niques based on work done in the lab of
company founder Robert Margolskee,
M.D., Ph.D., now at Monell Chemical
Senses Center. The public company
currently has $7.5 million in cash.
As industry focus has shifted to finding
natural ingredients, Redpoint has devel-
oped some new variations on classical
pharmacology to find new compounds.
‘‘We’ve gone back to behavioral models
of taste,’’ said Raymond Salemme, Ph.D.,
Redpoint Bio CEO. But natural products
are often impure and can produce off-
target effects in cell-based assays that
are often difficult to sort out. To comple-
ment its cell-based assays, Redpoint
employs trained rodents. ‘‘It is classical
Skinner box stuff,’’ said Salemme. ‘‘You
can train an animal to make a discrimina-
tion. If they make the right discrimination,
they press a lever and they get a food
pellet. We have computerized everything
and put a sample plate under the bottom
of the animal’s cage, providing fairly high
sample throughput. The animal sticks his
tongue in a well and interrupts a laser
beam. We can see how many times the
animal actually licks the sample to see
how much he likes it. ’’
According to Salemme, researchers
have observed that the symptoms of dia-
betes frequently cease in morbidly obese
people who undergo radical bariatric
surgery. This is consistent with the pro-
posed role of taste or related chemosen-
sory signaling circuits in the gut that can
provide feedback signals that control
hunger and metabolism. Redpoint Bio is
working on developing compounds that
work on gut signaling as novel therapies
for diabetes.2009 ª2009 Elsevier Ltd All rights reservedRedpoint Bio uses cheminformatic
approaches for navigating chemical
space to find new natural products with
desirable taste properties. ‘‘One thing
that people are interested in is finding
natural high-potency sweeteners that
come from a fermentation source that
could be cheaper to produce than farming
plants like stevia,’’ said Salemme. How-
ever, Redpoint Bio has no current funded
collaborations. ‘‘It has been a rough envi-
ronment for biotech,’’ says Salemme.
Some consumer advocates question
the regulation of these new flavor ingredi-
ents. As they appear in minute quantities,
they are not identified on product labeling.
Potentially more controversial is the ques-
tion if the tongue and brain registers
something as sweet that really isn’t,
does the metabolism concur?
‘‘To play with the taste perception may
not be harmful’’ said Bedrich Mosinger,
M.D., Ph.D., senior research associate,
Monell Chemical Senses Center. ‘‘How-
ever, we find taste receptors on endocrine
cells in the body. We currently study in
detail their physiological role, but we
already know that they participate in regu-
lation of release of several hormones.
Therefore, agents that affect taste may
also affect hormonal balance.’’ Who could
imagine that feeding our sweet tooth
could be so complicated?
‘‘We are responding to our clients’
desires and they are responding to con-
sumers desires.’’ said Jeannine Delwiche,
Ph.D. senior scientist at flavor giant Fir-
menich. ‘‘The dream compound would
be something that would be sweet,
cheap, natural, and low calorie without
side effects, and we’d like it to have the
same functional properties as sucrose.’’
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